✦ LIBER ✦

Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophrenia

✍ Scribed by H. Ascher-Svanum; X. Peng; W. Montgomery; D.E. Faries; A.H. Lawson; M.M. Witte; D. Novick; N. Jemiai; E. Perrin; D.P. McDonnell

Book ID: 118440064
Publisher: Elsevier Science
Year: 2011
Tongue: French
Weight: 393 KB
Volume: 26
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2010.03.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH12 Risk of Relapse and Hospitalizatio

PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine

✍ D. Novick; H. Ascher-Svanum; J. Bertsch; H. Detke; D. Mcdonnell; M. Witte; J. Ha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMH67 ORAL SUPPLEMENTATION AND CONCOMITA

PMH67 ORAL SUPPLEMENTATION AND CONCOMITANT MEDICATION IN THE TREATMENT OF SCHIZOPHRENIA WITH LONG-ACTING ATYPICAL ANTIPSYCHOTICS

✍ H Ascher-Svanum; X Peng; W Montgomery; DE Faries; AH Lawson; M Witte; D Novick; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Impact of risperidone long-acting inject

Impact of risperidone long-acting injection verus oral antipsychotic treatments on hospitalization in schizophrenia

✍ J.M. Olivares; A. Morales Rodriguez; J. Diels; M. Povey; A. Lam; Z. Zhao 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 44 KB

PMH21 COST-EFFECTIVENESS OF OLANZAPINE L

PMH21 COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION IN THE TREATMENT OF NON-ADHERENCE PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES

✍ H Ascher-Svanum; NM Furiak; RW Klein; W Montgomery; LJ Smolen; AH Lawson; RR Con 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB